Views & Analysis World Alzheimer's Day: latest research and a carer's perspec... On World Alzheimer’s Day, pharmaphorum looks at statistics, current research and the impact of dementia on families.
News Biogen drug shows potential in Alzheimer's Phase 1b trial shows aducanumab clears brain plaques.
Views & Analysis After 2015's ‘breakthrough’ year for pharma approvals, will ... Roche's MS drug is among major drugs still to come in 2016.
News Lilly pays AstraZeneca $100m as Alzheimer's drug enters phas... AstraZeneca and Eli Lilly are to continue with a pivotal phase 2/3 study of a key pipeline drug, AZD3293 for early Alzheimer's disease, after interim safety data boosted confidence in the d
News AI specialists Enveda and Basecamp rake in the cash AI-powered drug discovery companies Enveda and Basecamp have completed impressive funding rounds, worth $311m and $140m, respectively.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
